Evidence map›Paper›PMID 41599598›Full record

ArticlePolymers2026

Synthesis and Degradation Behavior of Poly(glycerol sebacate)-Isophorone Diisocyanate Scaffolds Reinforced with Hydroxyapatite for Biomedical Applications.

Aleksandra Korbut, Agnieszka Sobczak-Kupiec, Monika Biernat, Sonia Zielińska

Abstract read
In one paragraph

Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aleksandra KorbutDepartment of Polymer Engineering and Technology, Faculty of Chemistry, Wroclaw University of Science and Technology (WUST), Wyb. Wyspianskiego 27, 50-370 Wroclaw, Poland.ORCID 0000-0001-7982-9038
Agnieszka Sobczak-KupiecDepartment of Materials Engineering, Cracow University of Technology, Jana Pawła II Av. 37, 31-864 Cracow, Poland.ORCID 0000-0003-0005-6146
Monika BiernatBiomaterials Research Group, Ceramic and Concrete Division in Warsaw, Łukasiewicz Research Network Institute of Ceramics and Building Materials, Postępu 9, 02-676 Warsaw, Poland.ORCID 0000-0002-5692-0653
Sonia ZielińskaDepartment of Polymer Engineering and Technology, Faculty of Chemistry, Wroclaw University of Science and Technology (WUST), Wyb. Wyspianskiego 27, 50-370 Wroclaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poly(glycerol sebacate) (PGS) is a biodegradable elastomer with high potential for tissue engineering. However, its limited structural stability and degradation control restrict broader biomedical applications. This study presents an integrated fabrication strategy for highly porous PGS-IPDI scaffolds reinforced with two types of hydroxyapatite of distinct origin (HAP_B and HAP_ICMB). By combining low-temperature urethane crosslinking with thermally induced phase separation and salt leaching, we obtained scaffolds with interconnected micro-macroporous architectures and exceptionally high porosity (up to 98%). The comparative incorporation of phase-pure nanometric HAP_B and biphasic HAP_ICMB enabled the identification of composition-dependent differences in water uptake, structural stability, and mineralization tendencies. Furthermore, degradation behavior was systematically evaluated in four physiologically relevant media (PBS, SBF, artificial saliva, Ringer's solution), revealing distinct degradation pathways associated with each environment. The results provide new insight into how hydroxyapatite type and incubation medium collectively govern the long-term performance of chemically crosslinked PGS-based scaffolds.

Indexed as

biomaterialschemical crosslinkinghydroxyapatiteincubationpoly(glycerol sebacate)scaffolds

Identifiers

PMID41599598
PMCPMC12845658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.